For acute contact:  In a ---- hr-acute contact toxicity study, honey bees {species} were exposed to {test material} administered {topically to – region} at an application rate of {0 (negative control, solvent control), x1, x2, --- x_n µg a.i./bee} in accordance with the {…… specifiy the guideline followed}.  The NOEL and LD₅₀ values were X and X µg a.i./bee, respectively.  The test material is classified as [indicate the relative toxicity] to honey bees in accordance with the classification of Atkins (1981).

[Briefly describe mortality and sublethal effects.  If there is no toxicity, state that there were no compound related effects.  Compare with reference chemical toxicity, if used.]

This study is classified as [enter acceptability classification e.g. acceptable/unacceptable/ supplementary) and {satisfies/does not satisfy} the guideline requirement for acute contact toxicity study for honey bees.

For acute oral:  In a --- hr-acute oral toxicity study, honey bees {species} were exposed to {test material} administered in the feed solution at an application rate of {0 (negative control, solvent control), x1, x2, --- x_n µg a.i./bee) in accordance with the --- {specify the guideline followed}.  The NOEC and LC₅₀ values were X and X µg a.i./bee, respectively.  The test material is classified as [indicate the relative toxicity] to honey bees in accordance with the classification of Atkins (1981).

[Briefly describe mortality and sublethal effects.  If there is no toxicity, state that there were no compound related effects.  Compare with reference chemical toxicity.]

This study is classified as [enter acceptability classification e.g. acceptable/unacceptable/ supplementary) and {satisfies/does not satisfy} the guideline requirement for {acute oral toxicity} study for honey bees.

Results Synopsis:

      Test organisms and test organism age:

      Test type:

For acute contact:

      … hr LD₅₀:            {… µg a.i./bee}          95% C.I.:   {…  to …  µg a.i./bee}

      … hr NOEL:         {… µg a.i./bee}

      Probit Slope:         {…)                             95% C.I.:   {… to …}

      Endpoint(s) Effected:  {…}

For acute oral:

      ---- hr LC₅₀:           {… µg a.i./bee}          95% C.I.:   {…  to … µg a.i./bee}

      ---- hr NOEL:                                                                                          {… µg a.i./bee}

      Probit Slope:         {…}                            95% C.I.:   {… to …}

      Endpoint(s) Effected:  {…}